eligibility for glp 1 glp-1 Helping Qualified Medicare Patients Access Life-Changing Treatment. Are you a Medicare beneficiary Symbios Health | Have Medicare

While awaiting data release via dbGaP, investigators may contact the senior author (Wenzel) of this study or go to the SARP website (46) to access to the data via the ancillary study mechanism for SARP

Here is what nobody told you

Even in people without overt deficiency, B12 injections can correct subclinical insufficiency more rapidly than oral supplementation

Weight loss is the primary mechanism and FDA-approved indication for obesity formulations (Wegovy, Zepbound)

However, small sample sizes, short study durations, and inconsistent reporting mean that rare or long-term risks could easily have been missed

Furthermore, 40.4% of ICSRs involved hospitalized patients, 2.7% resulted in patient mortality, 0.9% led to disability, and 2.8% caused life-threatening reactions, while only 1.7% classified as non-serious outcomes